Updates from FDA

APhA Staff

Approximately 16.5 million adults in the United States live with atopic dermatitis (a form of eczema), while dry skin (xerosis) affects approximately 20% of the population at any given time.

Mary Warner

Millions of Americans use kratom to treat chronic pain, fatigue, depression, or anxiety, despite limited clinical evidence supporting its use.

Mickie Cathers

According to the results of a NEJM study from May 2025, as-needed use of albuterol-budesonide resulted in a lower risk of severe asthma exacerbation than use of albuterol alone, specifically among patients with uncontrolled mild asthma despite treatment.

Lauren Howell, PharmD

In September 2025, HHS announced actions it would take—including a letter to physicians and the beginning stage of a process for a safety label change—to address the potential risk of autism associated with prenatal acetaminophen exposure.

Sonya Collins